Breaking News Instant updates and real-time market news.

ETSY

Etsy

$32.97

-0.25 (-0.75%)

, ORCL

Oracle

$48.28

-0.17 (-0.35%)

08:53
06/14/18
06/14
08:53
06/14/18
08:53

On The Fly: Pre-market Movers

HIGHER: Etsy (ETSY), up 14% after introducing new tools, revising fee structure and updating FY18 guidance... Teligent (TLGT), up 17% after FDA approval of the company's abbreviated new drug application for Diflorasone Diacetate Ointment. DOWN AFTER EARNINGS: Tailored Brands (TLRD), down 16%... Michaels (MIK), down 17%. ALSO LOWER: Oracle (ORCL), down 2.5% after JPMorgan analyst Mark Murphy downgraded the stock to Neutral from Overweight... Aqua Metals (AQMS), down 9% after the company filed to sell common stock.

ETSY

Etsy

$32.97

-0.25 (-0.75%)

ORCL

Oracle

$48.28

-0.17 (-0.35%)

TLGT

Teligent

$3.28

0.01 (0.31%)

TLRD

Tailored Brands

$33.45

-0.95 (-2.76%)

MIK

Michaels

$21.94

0.19 (0.87%)

AQMS

Aqua Metals

$3.13

-0.13 (-3.99%)

  • 14

    Jun

  • 18

    Jun

  • 19

    Jun

  • 19

    Jun

  • 14

    Jun

ETSY Etsy
$32.97

-0.25 (-0.75%)

05/09/18
LOOP
05/09/18
NO CHANGE
Target $37
LOOP
Buy
Etsy price target raised to $37 from $32 at Loop Capital
Loop Capital analyst Laura Champine raised her price target on Etsy to $37, saying that despite the rally of the stock year-to-date, its momentum will likely continue amid the company's ongoing efforts to drive traffic to its platform. Champine expects FY18 revenue to grow 22% after a 25 increase in Q1, as the management "improves search functionality and works with sellers to drive incremental promoted listings and other seller services revenue streams". The analyst keeps her Buy rating on Etsy.
05/01/18
DADA
05/01/18
NO CHANGE
Target $35
DADA
Buy
Etsy price target raised to $35 at DA Davidson ahead of earnings
DA Davidson analyst Tom Forte raised his price target on Etsy to $35 from $33 and kept his Buy rating ahead of the company's earnings next week. Forte notes that despite the 70% rise in the stock price since early February, he continues to see value in shares as investors understand the company's "unique" business model and appreciate the management's execution. The analyst does see some near-term challenges for Etsy as its comparisons for its seller services business become tougher in the second half after the company's mandated payments platform in the second half of last year.
04/16/18
KEYB
04/16/18
NO CHANGE
Target $33
KEYB
Overweight
KeyBanc sees continued opportunity for Etsy to improve seller services
KeyBanc analyst Edward Yruma thinks Etsy has continued opportunity to improve seller services, and in turn, drive stronger revenue growth. The analyst notes that late last week, Etsy launched the capability for sellers to send targeted offers to customers with abandoned items in the cart, which he believes is a good example of Etsy providing better tools to its seller community and improving its take rate. Yruma has an Overweight rating and $33 price target on the stock.
04/10/18
04/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Sell at Vertical Group. 2. Philip Morris (PM) initiated with a Buy at Deutsche Bank. 3. Etsy (ETSY) initiated with a Buy at Loop Capital. 4. Zscaler (ZS) initiated with an Outperform at Credit Suisse and Baird, a Strong Buy at Needham, an Equal Weight at Morgan Stanley, Stephens, and Barclays, a Hold at Deutsche Bank, as well as a Neutral at BofA/Merrill and Goldman Sachs. 5. Equifax (EFX) initiated with an Underperform at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ORCL Oracle
$48.28

-0.17 (-0.35%)

06/14/18
NOMU
06/14/18
NO CHANGE
Target $60
NOMU
Buy
Oracle price target lowered to $60 from $64 at Nomura Instinet
Nomura Instinet analyst Christopher Eberle lowered his price target for Oracle to $60 ahead of the company's Q4 results on June 19. The analyst trimmed his estimates to account for currency and expectations for more modest revenue acceleration in fiscal 2019. He remains optimistic, however, on Oracle's transition and model growth reacceleration as the year progresses. Eberle keeps a Buy rating on the shares, which JPMorgan this morning downgraded to Neutral.
05/01/18
BERN
05/01/18
NO CHANGE
BERN
Amazon Aurora more expensive than oracle for enterprise workloads, says Bernstein
Bernstein analyst Mark Moerdler notes that there has been a generally held belief that Amazon (AMZN) Aurora was positioned to take customers and share from Oracle (ORCL) but that is "simply not true." Excluding the significant feature/functionality limitations of Aurora for the enterprise workloads that are core to the Oracle database business, Amazon has priced Aurora for small departmental workloads used possibly 8 hours a day/5 days a week, he contends. As the database workload grows in size and the data is accessed more frequently Aurora becomes less and less competitive, the analyst adds. Moerdler believes this debunks one major threat. For Amazon, he does not see this as a problem since there is a very large opportunity for departmental databases.
06/14/18
JPMS
06/14/18
DOWNGRADE
Target $53
JPMS
Neutral
JPMorgan downgrades Oracle after CIO survey shows spending contraction
JPMorgan analyst Mark Murphy downgraded Oracle (ORCL) to Neutral from Overweight and lowered his price target for the shares to $53 from $55. The stock closed yesterday down 18c to $48.27. The shares have risen from the $30s into the high $40s over the last two years, but the company's fundamental performance has remained inconsistent, Murphy tells investors in a research note. Further, the analyst notes that in his firm's recent survey of 154 chief investment officers, Oracle received the largest number of indications for planned spending contraction this year, materially more than the second-worst company. The CIOs indicate contraction in Oracle spending this year, placing the company alongside IBM (IBM), Checkpoint (CHKP), and CA (CA), Murphy contends. He notes the results of his firm's CIO surveys over the years "have been highly predictive."
06/14/18
JPMS
06/14/18
DOWNGRADE
Target $53
JPMS
Neutral
Oracle downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Mark Murphy downgraded Oracle to Neutral and lowered his price target for the shares to $53 from $55.
TLGT Teligent
$3.28

0.01 (0.31%)

04/18/18
CHLM
04/18/18
NO CHANGE
Target $7
CHLM
Buy
Teligent well positioned to return to rapid growth, says Craig-Hallum
Craig-Hallum analyst Matt Hewitt believes FDA's approval of Clobetasol Propionate Cream is important news that should drive shares of Teligent higher. Noting the large market size for the drug and his belief that Teligent is the 5th generic player to enter the market, the analyst estimates that the drug could potentially become the largest in the company's portfolio upon full ramp. Hewitt reiterates a Buy rating and $7 price target on the shares.
11/07/17
ADAM
11/07/17
DOWNGRADE
Target $5
ADAM
Hold
Teligent downgraded to Hold from Buy at Canaccord
Canaccord analyst Dewey Steadman downgraded Teligent to Hold from Buy following Q3 results. The analyst said its core business is declining, new launches have been delayed, and profitability has meaningfully eroded. Steadman lowered his price target to $5 from $9 on Teligent shares.
07/31/17
ADAM
07/31/17
INITIATION
Target $11
ADAM
Buy
Teligent initiated with a Buy at Canaccord
Canaccord Genuity analyst Dewey Steadman started Teligent with a Buy rating and $11 price target. The analyst expects the company to build a "comprehensive" topical derm portfolio and "meaningfully expand" its injectables franchise over the next several quarters.
TLRD Tailored Brands
$33.45

-0.95 (-2.76%)

06/14/18
JEFF
06/14/18
NO CHANGE
Target $40
JEFF
Buy
Tailored Brands earnings pullback a buying opportunity, says Jefferies
Jefferies analyst Randal Konik recommends using the post-earnings pullback today in shares of Tailored Brands as a buying opportunity. With stock having a strong run year-to-date, expectations into the print were somewhat elevated, Konik tells investors in a research note. JoS. A. Bank comps and gross margin were a touch light, but transactions are up, custom is growing, inventory is lean, and the balance sheet is cleaned up, the analyst contends. He sees improving sales trends, share gains, margin expansion and accelerating free cash flow generation benefiting shareholders with a two year view. Konik keeps a Buy rating on Tailored Brands with a $40 price target.
05/14/18
JEFF
05/14/18
UPGRADE
Target $40
JEFF
Buy
Tailored Brands upgraded to Buy from Hold at Jefferies
As previously reported, Jefferies analyst Randal Konik upgraded Tailored Brands to Buy from Hold with a $40 price target, telling investors in a research note that the company is on a path toward sustainable fundamental improvement and its legacy balance sheet issues are now behind it. Konik sees opportunities in custom clothing as well as a recovery in JoS. A Bank towards prior productivity levels.
06/04/18
JEFF
06/04/18
NO CHANGE
Target $40
JEFF
Buy
Jefferies recommends Tailored Brands after Jos. A. Bank deep dive
Jefferies analyst Randal Konik says a deep dive into Tailored Brands' Jos. A. Bank business, which represents more than 20% of sales, left him increasingly confident in the sustainability of the brand's recovery. Data show Bank's marketing and merchandise initiatives are taking hold, while significant upside remains given productivity levels that are well-below peak and Men's Warehouse, Konik tells investors in a research note. He reiterates a Buy rating on Tailored Brands with a $40 price target.
05/14/18
JEFF
05/14/18
UPGRADE
JEFF
Buy
Tailored Brands upgraded to Buy from Hold at Jefferies
MIK Michaels
$21.94

0.19 (0.87%)

04/23/18
WELS
04/23/18
INITIATION
Target $20
WELS
Market Perform
Michaels initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Zachary Fadem started Michaels with a Market Perform rating and $20 price target.
03/23/18
SPHN
03/23/18
NO CHANGE
Target $26
SPHN
Overweight
Michaels price target cut to $26 following Q4 results at Stephens
Stephens analyst Rick Nelson lowered his price target on The Michaels Companies to $26 from $30 following the company's in-line Q4 results. In a research note to investors, Nelson noted that the company's guidance fell well below the consensus, adding that the company is planning to utilize one third of its tax reform benefits to invest in strategic initiatives, like re-formatting 235 stores, and is planning to close 94 Aaron Brothers locations. Nelson continues to like Michaels' high operating margins, strong free cash flow and stock buybacks. Nelson backed his Overweight rating.
03/23/18
JPMS
03/23/18
NO CHANGE
Target $27
JPMS
Overweight
Michaels pullback yesterday a buying opportunity, says JPMorgan
JPMorgan analyst Christopher Horvers recommends using the pullback yesterday in shares of Michaels as a buying opportunity. While the earnings and operating income guidance was disappointing, the story is intact and the company's digital investments should "widen its lead," Horvers tells investors in a post-earnings research note. Michaels has 12% of its market capitalization in cash, which can be deployed in a 10% accretive accelerated share repurchase or for strategic ends, the analyst contends. He lowered his price target for the shares to $27 from $30 and keeps an Overweight rating on Michaels.
03/22/18
LOOP
03/22/18
NO CHANGE
Target $21
LOOP
Hold
Michaels price target lowered to $21 from $25 at Loop Capital
Loop Capital analyst Laura Champine lowered her price target for Michaels to $21 citing the company's "weak" margin guidance. The analyst, however, believes the stock already prices in today's lower margin guidance. She keeps a Hold rating on Michaels.
AQMS Aqua Metals
$3.13

-0.13 (-3.99%)

06/11/18
HCWC
06/11/18
NO CHANGE
Target $9
HCWC
Buy
Aqua Metals starting lead production addresses overhang, says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal said Aqua Metals' announcement that it has begun production of high grade AquaRefined lead that meets standards required for London Metals Exchange addresses a "significant overhang" about the viability of the technology. He maintains a Buy rating and $9 price target on Aqua Metals shares, which are up 5% to $3.10 in early trading.
06/22/17
06/22/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jabil Circuit (JBL) initiated with an Outperform at Macquarie. 2. Magellan Midstream (MMP) initiated with a Hold at Jefferies. 3. AvalonBay (AVB) initiated with a Buy at Argus. 4. Aqua Metals (AQMS) initiated with a Buy at Rodman & Renshaw. 5. Del Taco (TACO) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/17
RODM
06/22/17
INITIATION
Target $25
RODM
Aqua Metals initiated with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Amit Dayal initiated Aqua Metals (AQMS) with a Buy and a $25 saying strategic alliances with Johnson Controls (JCI), Interstate Batteries, and Battery Systems validates the company's technology and provides visibility into revenues.

TODAY'S FREE FLY STORIES

SPWR

SunPower

$8.09

(0.00%)

09:40
06/20/18
06/20
09:40
06/20/18
09:40
Options
Rev/Con recap for Jun 19th »

Rev/Con recap for Jun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$39.90

(0.00%)

09:39
06/20/18
06/20
09:39
06/20/18
09:39
Recommendations
PG&E analyst commentary  »

Morgan Stanley sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

09:37
06/20/18
06/20
09:37
06/20/18
09:37
Conference/Events
House Financial Services Committee to hold a hearing »

The Terrorism &…

MKSI

MKS Instruments

$103.90

(0.00%)

, SSNLF

Samsung

$0.00

(0.00%)

09:36
06/20/18
06/20
09:36
06/20/18
09:36
Recommendations
MKS Instruments, Samsung analyst commentary  »

MKS Instruments offers…

MKSI

MKS Instruments

$103.90

(0.00%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

09:35
06/20/18
06/20
09:35
06/20/18
09:35
General news
U.S. existing home sales preview: »

U.S. existing home sales…

GE

General Electric

$12.96

(0.00%)

09:34
06/20/18
06/20
09:34
06/20/18
09:34
Recommendations
General Electric analyst commentary  »

GE's 'here to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:34
06/20/18
06/20
09:34
06/20/18
09:34
Hot Stocks
Johnson says 'not immune' to geopolitical events, focused on long-term in China »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

AMZN

Amazon.com

$1,735.74

(0.00%)

, JPM

JPMorgan

$107.58

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Hot Stocks
Amazon-Berkshire-JPMorgan healthcare joint venture names Atul Gawande CEO »

Amazon (AMZN), Berkshire…

AMZN

Amazon.com

$1,735.74

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

ITRI

Itron

$58.50

(0.00%)

, SPKE

Spark Energy

$10.30

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Recommendations
Itron, Spark Energy analyst commentary  »

Itron added to Best Ideas…

ITRI

Itron

$58.50

(0.00%)

SPKE

Spark Energy

$10.30

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$44.72

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson trends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
06/20/18
06/20
09:30
06/20/18
09:30
General news
The U.S. current account gap widened »

The U.S. current account…

VHC

VirnetX

$3.45

(0.00%)

09:29
06/20/18
06/20
09:29
06/20/18
09:29
Hot Stocks
VirnetX enters reseller agreement with Above PAR Advisors »

VirnetX has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$33.21

(0.00%)

, SRPT

Sarepta

$143.92

(0.00%)

09:27
06/20/18
06/20
09:27
06/20/18
09:27
Recommendations
PTC Therapeutics, Sarepta analyst commentary  »

PTC Therapeutics weakness…

PTCT

PTC Therapeutics

$33.21

(0.00%)

SRPT

Sarepta

$143.92

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

AMZN

Amazon.com

$1,735.74

(0.00%)

, BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Breaking Hot Stocks news story on Amazon.com, Berkshire Hathaway, Berkshire Hathaway, JPMorgan »

Amazon, Berkshire,…

AMZN

Amazon.com

$1,735.74

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

TLGT

Teligent

$3.70

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Teligent announces FDA approval of Fluocinonide Gel, 0.05% »

Teligent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$207.24

(0.00%)

, TST

TheStreet

$1.78

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
S&P Global confirms purchase of RateWatch business from TheStreet »

S&P Global (SPGI)…

SPGI

S&P Global

$207.24

(0.00%)

TST

TheStreet

$1.78

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
06/20/18
06/20
09:25
06/20/18
09:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD topped…

AZZ

AZZ Inc.

$44.93

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Energy Subcommittee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTEX

Mannatech

$20.40

(0.00%)

09:24
06/20/18
06/20
09:24
06/20/18
09:24
Hot Stocks
Mannatech announces final results of modified Dutch auction tender offer »

Mannatech announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$127.56

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Hot Stocks
Starbucks CEO says 'some canibalization,' new entrants hurt China SSS in Q3 »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EMCI

EMC Insurance

$27.28

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Upgrade
EMC Insurance rating change  »

EMC Insurance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIN

Kindred Biosciences

$10.00

(0.00%)

09:20
06/20/18
06/20
09:20
06/20/18
09:20
Syndicate
Kindred Biosciences 4.632M share Spot Secondary priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

RUT

Russell 2000 Index

$0.00

(0.00%)

, IWM

iShares Trust Russell 2000 Index Fund

$168.64

(0.00%)

09:20
06/20/18
06/20
09:20
06/20/18
09:20
Technical Analysis
Technical Take: iShares Trust Russell 2000 Index Fund hits new life high »

In pre-market trading the…

RUT

Russell 2000 Index

$0.00

(0.00%)

IWM

iShares Trust Russell 2000 Index Fund

$168.64

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.